Kaneka Ubiquinol Attend Successful “Strong Sustainable Growth” CMA conference

Konichiwa! G’Day Mito! Kaneka Corporation were thrilled to attend the Complementary Medicines Australia (CMA) Annual Conference and 24th Awards Industry Dinner 2023, where we highlighted and educated on the numerous benefits of ubiquinol for mitochondrial health to industry leaders and brandholders.

Themed “Strong Sustainable Growth”, Kaneka Ubiquinol joined the conversations dedicated to the exploration of both economic and business sustainability, as well as environmental stewardship.

Opening the conference, the largest ever, CEO John O’Doherty said, “as we welcome you all to this annual Complementary Medicines Australia conference, we are filled with inspiration by all our members whose outstanding products support optimal wellbeing for millions across the globe – for good health, socially and economically, for impact that reaches far and wide. We are honoured to be your collective association.”

An outstanding day of insights and learnings from key industry leaders in nutraceuticals, raw material suppliers, manufacturing, wellbeing, audience insights and employee wellness programs as Australia continues to light the path of excellence on the global complementary medicines stage.

Kaneka’s deep commitment to a successful sustainability strategy that commits to best-in-class sustainable manufacturing, responsible sourcing and supporting the wellbeing of humans across the world is the top priority of the brand. Inspired by the Japanese philosophy of kaizen – continuous improvement is embedded in the values across the organisation.

As a leader in the industry, Kaneka is dedicated to advancing the science behind ubiquinol, offering a unique perspective on its role in supporting overall health and wellbeing, including cardiovascular health, energy and production and reproductive health.

Kaneka’s Ubiquinol, the potent antioxidant produced via a unique patented yeast fermentation process with precision Japanese manufacturing, whose footprint across the Australasia has seen meteoric growth based on consumer demand for mitochondrial health support.